Hexagon Nutrition LimitedPharmaceuticals & HealthcareHEXAGON
Q1 FY27 concall · earnings callHexagon Nutrition Limited
The company started FY27 with strong revenue growth of 43.2% and has a robust order book, focusing on expanding its branded business and mitigating margin pressures.
Numbers
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Consolidated Revenue | ₹104.3 Cr | 43.2% | |
| EBITDA | ₹11.8 Cr | 17.3% | |
| Profit After Tax | ₹8.1 Cr | 25.1% | |
| EBITDA Margin | 11.3% | — | |
| Capacity Utilization | 47% | — |
TL;DR
- Consolidated revenue grew 43.2% year-on-year to INR104.3 crore.
- Profit after tax grew 25.1% to INR8.1 crore.
- EBITDA margin declined to 11.3% due to raw material costs and freight increases.
- Order book stands at INR100 crore for execution in Q2 and Q3.
- Management guided for 20-25% revenue growth for FY27 and expects to pass on cost increases to customers.
Said on the call
“We have started FY '27 on a very strong note with a healthy year-on-year growth in both revenue and profitability.”
From the Q&A
| Topic | What management said |
|---|---|
| Export Concentration | Top five export countries contribute 25% to 40% of total exports; West Asia contributes less than 20% of exports. |
| Capacity Utilization | Blended capacity utilization is 47%; premix drives over 50% of revenue; facility utilization varies: Nashik 55-60%, Chennai 25-30%, Tuticorin 35-40%. |
| Revenue Growth Guidance | Guidance is for 20% to 25% revenue growth for FY27, considered conservative; Q2 has a strong order book of INR100 crore. |
| Segment Mix and Growth | Revenue mix: branded 28%, premix 62%, therapeutic (ESG) 10%; branded segment grew 28% year-on-year; aim for branded to reach 35% of revenue in a couple of years. |
| Margin Compression and Mitigation | Gross margin contracted over 3% due to West Asia crisis increasing raw material and freight costs; management has increased MRP by 10-15% to pass on costs, expecting relief in coming quarters. |
| Volume vs Price Growth | Volume grew 25% to 40% this quarter; price hikes were not the main driver, but MRP increases on some branded products will impact Q2. |
| Other Expenses Increase | Increase in other expenses is due to higher freight costs and strategic investments in sales force and marketing, with field force increased by more than 50%. |
| Cash Flow and Working Capital | Operating cash flow improved; inventory days are around 142 days due to strategic stocking for order book; no major changes in credit terms. |
Guidance
- Revenue growth guidance of 20% to 25% for FY27.
- Expect branded business to reach 35% of total revenue in a couple of years.
- Plan to pass on raw material cost increases via MRP hikes of 10-15% in coming quarters.
- Expect operating leverage to improve as capacity utilization increases and new sales force becomes productive.
Source
Summary written from the transcript filed by Hexagon Nutrition Limited for the call held on 14 Aug 2026; published 18 Aug 2026, 20:10 IST.
More Q1 FY27 concalls ·How verification works ·Report an error